CALI (CalciMedica Inc) Bozor qiymatining balans qiymatiga nisbati
Dori vositalarini ishlab chiqish xarajatlari tufayli foyda o'sishining to'xtab qolishi CalciMedica, Inc. (CALI) moliyaviy dinamikasini belgilaydi. Bozor qiymatining balans qiymatidan farq qilishi aktivning joriy premiumini ko'rsatadi, bunda 0.00 belgisi joriy ko'rsatkich vazifasini o'taydi. Inhibitorlarga tegishli eksklyuziv patentlar biznes uchun himoya to'sig'ini yaratadi, biroq FDA ning qat'iy nazorati va klinik sinovlarning muvaffaqiyatsiz tugash xavflari aksiyalar narxiga sezilarli bosim o'tkazmoqda.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_CALI_-_CalciMedica-Inc._-_Market-Capitalization-to-Net-Assets "CALI CalciMedica Bozor kapitallashuvining balans qiymatiga nisbati (11.10.2024 - 17.10.2026) | 👁️GURU.Markets👁️")
CalciMedica, Inc. (CALI) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati CalciMedica, Inc.|CALI - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati calcimedica.com|CALI - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar CalciMedica Corp|CALI - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari CalciMedica
Kompaniyaning dastlabki tahlili:CalciMedica Inc - CALI
Ushbu koeffitsiyent bozor kompaniya aktivlarini ularning balans qiymatiga nisbatan qanchalik hadda haddan tashqari yuqori baholashini aks ettiradi. Bozor qiymatining balans qiymatiga nisbati o'zgarishini tahlil qilish orqali investor birja narxi va haqiqiy kapital o'rtasidagi farqni aniqlashi mumkin. Ushbu ko'rsatkich bozor kapitalizatsiyasini umumiy kapitalga bo'lish orqali hisoblanadi. Yuqori qiymatlar ko'pincha kelajakdagi muvaffaqiyatlar kutganlari bilan bog'liq bo'lib, CalciMedica, Inc. (CALI) uchun bu organlarni davolash uchun innovatsion kalsiy inhibitorlarini ishlab chiqish bilan bog'liqdir.
Asosiy raqobatchilar
argenx SE - Bozor kapitallashuvining balans qiymatiga nisbati|BNTX (biontech.de) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AbCellera Biologics (ABCL)|Bozor kapitallashuvining balans qiymatiga nisbati TRML|Precigen Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|PHAR: Bozor qiymatining balans qiymatiga nisbati|NKTR: Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|IMNM (Immunome Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GOSS|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals KALV|Kapitallashuvning balans qiymatiga nisbati septerna.com (SEPN)|PVLA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Savara Inc SVRA|RIGL: Bozor kapitallashuvining balans qiymatiga nisbati|ANAB - Kapitallashuvning sof aktivlarga nisbati|ATXS: Bozor kapitallashuvining balans qiymatiga nisbati|ENGN (engene.com) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati RAPT Therapeutics|Bozor qiymatining balans qiymatiga nisbati Aerovate|Bozor kapitallashuvining balans qiymatiga nisbati ACRS (Aclaris)|Kapitallashuvning sof aktivlarga nisbati Kyverna Therapeutics, Inc (KYTX)|Bozor kapitallashuvining balans qiymatiga nisbati TLSA|cabalettabio.com - Balans qiymatiga nisbatan bozor kapitallashuvi|VTYX: Bozor qiymatining balans qiymatiga nisbati|THTX - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati AVTX|Eledon Pharmaceuticals, Inc (ELDN) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati Agenus (AGEN)|Kapitallashuvning balans qiymatiga nisbati climbbio.com|ZURA (Zura Bio) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi aTyr Pharma Inc (ATYR)|Adagene Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati ImageneBio IMA|Shattuck Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Equillium, Inc. (EQ) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati connectbiopharm.com CNTB|Immunic (IMUX) - Balans qiymatiga nisbatan bozor qiymati|ATRA: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi IFRX|Bozor qiymatining balans qiymatiga nisbati X4 Pharmaceuticals XFOR|Kapitallashuvning balans qiymatiga nisbati adicetbio.com (ACET)|Celularity - Bozor kapitallashuvining balans qiymatiga nisbati|INMB - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning sof aktivlarga nisbati BRNS (Barinthus Bio)|KZR - Balans qiymatiga nisbatan bozor kapitallashuvi|SABS (SAB Biotherapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|akaritx.com (AKTX) - Kapitallashuvning sof aktivlarga nisbati|ENLV (Enlivex Therapeutics Ltd) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati QTTB|Bozor qiymatining balans qiymatiga nisbati GeoVax Labs Inc (GOVX)|Bozor qiymatining balans qiymatiga nisbati Edesa Biotech Corp (EDSA)|Bozor kapitallashuvining balans qiymatiga nisbati IBIO|Carisma Therapeutics Inc - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati XTL Biopharmaceuticals Ltd.|BOLT - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati hcwbiologics.com HCWB|Aptevo Therapeutics Inc. (APVO) - Balans qiymatiga nisbatan bozor qiymati|AIM (AIM ImmunoTech Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ADTX|GRI Bio (GRI) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati XRTX (XORTX Therapeutics Inc)|ReShape Lifesciences - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Revelation Biosciences Corp REVB|Indaptus Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|scinai.com (SCNI) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati affimed.com AFMD|Allakos (ALLK) - Balans qiymatiga nisbatan bozor qiymati|HOOK: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi IGMS|Bozor qiymatining balans qiymatiga nisbati ITOS (iTeos Therapeutics)|Kapitallashuvning sof aktivlarga nisbati OCEA (oceanbiomedical.com)|TC BioPharm - Bozor qiymatining balans qiymatiga nisbati|THRD - Kapitallashuvning sof aktivlarga nisbati